|
|
|
|
|
by trapperkeeper74
3190 days ago
|
|
The current answer is we don’t yet have full functional pathologies of types of depression, noninvasive, specific mood disorders classified down to exact neurological dysfunctions, accurate and precise knowledge of how existing antidepressants work and evidenced-based application of particular therapies based on such scientifically-identified presentations. Clinical psychiatry has been mostly a scattergun, guesswork that lacks scientific rigor. For example, I just tapered-off mirtazepene as it stopped working after 9 years and, so far, bupropion isn’t helping. I’d really like to try S32212 if it proves safe enough in human models because it likely lacks the GI and weight-gain issues. |
|